Mangoceuticals, Inc. (MGRX)
NCM · Health Information Services
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Peers in Health Information Services
All in industry →Veeva Systems Inc.
BrightSpring Health Services, Inc.
Tempus AI, Inc.
HealthEquity, Inc.
Waystar Holding Corp.
Doximity, Inc.
10x Genomics, Inc.
Privia Health Group, Inc.
Hinge Health, Inc.
HeartFlow, Inc.
Recent press releases
Mangoceuticals, Inc. has not issued a press release in this window.
SEC filings
All filings →Mangoceuticals, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Mangoceuticals, Inc. has no reported insider trades in the last 90 days.